Podcasts about cancer therapies

This week on our Live Show we discussed Trump Tarriffs illegal, Nato fotress in Romania, arson firefighter, ebbing asylum hotel, health and more Donations https://www.awakeningpodcast.org/support/ #awakening #brainfitness #Romania About my Co-Host:Arnold Beekes Innovator, certified coach & trainer and generalist. First 20 years in technology and organizational leadership, then 20 years in psychology and personal leadership (all are crucial for innovation). What we Discussed: 00:26 What the Picture on our Introduction Means 01:15 What we will be discussing in this weeks Show03:00 LeeuWarden Update05:20 Why Courts Can Not be Trusted06:30 How you can Help the Podcast07:25 Trumps Tariffs are Illegal10:10 Is the US a Dictatorship12:20 NATO Building its Largest Military Base in Romania  14:30 Arsonist was a Firefighter17:24 Shariah law recognised in Austria19:12 The dangers of the Burka20:05 Epping Asylum Hotel Cout Case Overturned25:20 Are You Working on Brain Fitness26:45 Google New Phone Pixel 1030:40 Googles Jules 2.032:30 ChatGpt Court case for causing Suicide36:40 Denmark make your Face and Voice as your IP39:17 How a Virtual Assistant Can Help your Business40:00 Cancer Therapy for Cat might help Humans41:25 From Fishing and Oil Disaster to Farming43:50 Spirecord Repair46:00 Universal Health Trackers48:05 The dangers of Devices that use WiFi48:45 Organipeel has been discontinued51:25 More than 2 Billion lack access to Safe Drinking Water56:35 Pure Human by Greg Braden58:00 Mecico's Massive Poverty Reduction1:00:40 Flight Pattern of Birds How to Contact Arnold Beekes: https://braingym.fitness/ https://www.linkedin.com/in/arnoldbeekes/ Donations ⁠⁠ https://www.awakeningpodcast.org/support/ https://www.podpage.com/speaking-podcast/support/ ⁠⁠ All about Roy / Brain Gym & Virtual Assistants athttps://roycoughlan.com/ 

Could cancer treatment be approached in a way that restores the body instead of breaking it down? In this powerful conversation, Dr. Hotze sits down with Dr. Nathan Goodyear, a leader in integrative oncology, to discuss how addressing the root causes of cancer can help patients achieve better health outcomes and an improved quality of life. Dr. Goodyear explains how his approach focuses on supporting the immune system, reducing inflammation, and using natural, targeted therapies that work with the body's healing processes. They explore how factors like the immune system, nutrition, toxins, tubal ligation, hysterectomy, mitochondria, and hormone imbalances play a role in overall impacts on your health, unnecessary symptoms, and even the potential development of cancer, and how restoring balance can help assist the body's ability to fight back in resolving symptoms and illnesses. If you or someone you love is facing cancer, this episode will open your eyes to treatment strategies that prioritize health, wellness, and quality of life over the one-size-fits-all approach of conventional medicine. For more information about Dr. Goodyear and other resources discussed today, please visit the following.   @ Dr.Goodyear (Instagram) https://www.instagram.com/dr.goodyear/?hl=en Website URLs: https://williamscancerinstitute.com/ https://pre-scribed.com/ https://www.off-scriptrx.com/ https://www.docgoodyear.com/ https://metabolicregen.com/   Watch now and subscribe to our podcasts at www.HotzePodcast.com. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce key developments following the company's annual and special meeting of shareholders, held in July. Bokhari reported that shareholders voted overwhelmingly in favor of all resolutions, including the election of all eight director nominees—two of whom are new to the board. Among the newly elected directors is The Honorable Cathy McMorris Rodgers, a veteran public servant with more than three decades of leadership experience. McMorris Rodgers represented Washington's 5th Congressional District from 2004 to 2025 and previously served as Republican Leader in the Washington State House of Representatives—the first woman to hold that role. Bokhari described her as a people-first, mission-driven leader whose policy acumen and bipartisan leadership will bring tremendous value to Medicus Pharma during its next phase of growth. Also joining the board is Ajay Raju, a well-known attorney, venture capitalist, and entrepreneur. Raju is Chairman and CEO of Raju LLP, Managing Partner of 215 Capital, and Co-founder of Avstera Therapeutics, with leadership roles across 16 portfolio companies. His legal, financial, and strategic expertise further strengthens the company's board as it advances clinical development and business expansion. In addition to governance updates, Bokhari revealed that Medicus has submitted a comprehensive briefing package to the U.S. Food and Drug Administration (FDA) requesting a Type C meeting. The company is seeking formal FDA feedback on its D-MNA (Dermal Methylnaltrexone) development program aimed at treating Basal Cell Carcinoma (BCC) of the skin. The proposed Phase 2 clinical trial (SKNJCT-003) will be a randomized, double-blind, placebo-controlled, multi-center study enrolling up to 60 participants. Subjects will be randomly assigned in equal numbers to receive either a Placebo, low-dose D-MNA, or high-dose D-MNA. The trial is designed to evaluate efficacy and safety outcomes, with the goal of accelerating the development of a novel topical therapy for one of the most common forms of skin cancer. With a strengthened leadership team and a clear regulatory strategy, Medicus Pharma is positioning itself for a pivotal year ahead in both corporate development and clinical advancement. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch #SkinCancer #BasalCellCarcinoma #BiotechNews #CancerResearch #UAEHealth #NonInvasiveTherapy #Doxorubicin #ClinicalTrials #HealthcareInnovation

In this episode: EMPOWER-SMS GP helps bridge the gap in post treatment support Reinforces medication adherence, especially for endocrine therapy Encourages achievable lifestyle changes that align with healthcare professionals’ goals Easy to implement with minimal healthcare professionals or admin workload Strengthens primary care’s role in survivorship and chronic care Host: Dr Rebecca Overton | Total Time:34 mins Experts: Dr Anna Singelton, Senior Research Fellow; Prof Elisabeh Elder, Specialist Breast Surgeon; A/Prof Carolyn Ee, Academic General Practitioner; Robyn Kelly, High school teacher Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

Dr. Abe Delpassand, Founder, CEO, and Chairman of the Board at RadioMedix, is concentrated on the development of radiopharmaceuticals for cancer diagnosis and treatment. Advancements in handling radioactive materials and increased availability have enabled the growth of the use of alpha-emitting and beta-emitting radioisotopes in treating cancers that have been resistant to other therapies. Alpha-emitting radioisotopes are particularly interesting because they can cause double-strand DNA damage in cancer cells, making the probability of cancer recurrence much less likely. Abe explains, "Just a brief introduction related to what radiopharmaceuticals are. These are drugs that have three parts, basically. One part is the radioactive material. The second part is what we call a ligand. It's like a vehicle that takes the radioactive material to the target that we have. And there is a third component, which is like a chain attaching the radioisotope to the ligand. Radiopharmaceuticals qualify as a form of therapy because we target a specific receptor antigen metabolic pathway in cancer cells, and this is how we can reach the cancer cells. It has two components: one, diagnostic and therapeutic, which is very unique to this modality because in many other cancer therapies before the treatment, we don't have any way to make sure that the patient who is receiving the treatment, that actually the drug can reach the cancer the patient has." "We have been talking about the value of alpha-emitters in delivering high level of radiation in a targeted fashion to the cancer cells, but we in the last, I'd say 10 years or more, we have learned how to handle these isotopes. That's one aspect of the science part. The other aspect is the availability of these isotopes. Now the supply of these isotopes is becoming a lot more, and they are becoming more available."    #RadioMedix #TeamRadioMedix #Radiopharmaceuticals #TargetedAlphaTherapy #OncologyInnovation #NuclearMedicine #CancerResearch #RadiogandTherapy #PrecisionOncology #Theranostics #SPICACenter #OncologyCommunity #AlphaEmittingRadioisotopes #BetaEmittingRadioisotopes radiomedix.com Download the transcript here

Dr. Abe Delpassand, Founder, CEO, and Chairman of the Board at RadioMedix, is concentrated on the development of radiopharmaceuticals for cancer diagnosis and treatment. Advancements in handling radioactive materials and increased availability have enabled the growth of the use of alpha-emitting and beta-emitting radioisotopes in treating cancers that have been resistant to other therapies. Alpha-emitting radioisotopes are particularly interesting because they can cause double-strand DNA damage in cancer cells, making the probability of cancer recurrence much less likely. Abe explains, "Just a brief introduction related to what radiopharmaceuticals are. These are drugs that have three parts, basically. One part is the radioactive material. The second part is what we call a ligand. It's like a vehicle that takes the radioactive material to the target that we have. And there is a third component, which is like a chain attaching the radioisotope to the ligand. Radiopharmaceuticals qualify as a form of therapy because we target a specific receptor antigen metabolic pathway in cancer cells, and this is how we can reach the cancer cells. It has two components: one, diagnostic and therapeutic, which is very unique to this modality because in many other cancer therapies before the treatment, we don't have any way to make sure that the patient who is receiving the treatment, that actually the drug can reach the cancer the patient has." "We have been talking about the value of alpha-emitters in delivering high level of radiation in a targeted fashion to the cancer cells, but we in the last, I'd say 10 years or more, we have learned how to handle these isotopes. That's one aspect of the science part. The other aspect is the availability of these isotopes. Now the supply of these isotopes is becoming a lot more, and they are becoming more available."    #RadioMedix #TeamRadioMedix #Radiopharmaceuticals #TargetedAlphaTherapy #OncologyInnovation #NuclearMedicine #CancerResearch #RadiogandTherapy #PrecisionOncology #Theranostics #SPICACenter #OncologyCommunity #AlphaEmittingRadioisotopes #BetaEmittingRadioisotopes radiomedix.com Listen to the podcast here

News: Latest News/Headlines | Traffic | Weather| Sports Topic I: Asylum sites to be expanded as ministers bid to end hotel use Topic II: World-first blood cancer therapy to be given on NHS Presenter(s): Imam Noorudin Jangeerkhan & Imam Shamail Ahmad Guest(s): Professor Giorgia Dona Asylum Aid Team- Kamena Dorling, Director of Policy Dr Khaled El-Ghariani Dr Majid Kazmi Researcher(s): Ghazala Bajwa, Eshaal Rana Nurah Owusuaah-Mensah, Maleeha Qamar & Jazeeba Zafrullah Khan Producer(s): Muneeb Mirza and Khaula Hashmi Assistant Trainee Producer: Maria Sheikh Lead Producer: Hania Yaqub

The wealth of bacteria resident on and in your body may have much to do with your overall health, including how you respond to different therapies for cancer. Johns Hopkins Kimmel Cancer Center director William Nelson explains views from a … Your gut microbiome may have much to do with how you respond to cancer therapy, Elizabeth Tracey reports Read More »

This episode discusses findings from a recent systematic review preprint, examining how the embryonic germ layer origin of various cancers may relate to differences in therapy response. Drawing on evidence from clinical trials and mechanistic studies, we explore patterns observed among mesoderm-, endoderm-, and ectoderm-derived tumors.The conversation highlights how integrating developmental biology concepts into oncology may help inform treatment decisions and research design. This episode is intended for students, researchers, and clinicians interested in cancer biology, translational research, and personalized medicine.Please note: The views of this podcast represent those of my guest and I, and do not constitute medical advice, recommendations or consultations. Please see a state certified and board certified professional for medical, advice and recommendations. We disclaim any loss in any way.Link to Preprint: Embryonic Germ Layer Origin as a Potential Determinant of Cancer Therapy Response: A Systematic Review and Meta-Analysis of Contemporary Evidence | medRxivNote: Some of this episode's production involved the use of AI.

This year's Randy Shaver Cancer Research and Community Fund's Angel Award recipient talks about his cutting edge work with Natural Killer Cell immunotherapy, CAR-T cell immunotherapy and the future of genome engineering in new therapies for treating cancer.Here how he became interested in creating new ways to look at knocking down cancer, his background as a youth growing up in rural Minnesota and trending as one of the most talked about researchers at the University of MN.

What if the key to treating disease wasn't to overpower the body—but to work with its existing systems?In this episode, I sit down with Frank Borriello, founder of Alloplex Biotherapeutics, to explore a new approach to therapy—one that uses natural immune regulation instead of chemical force. We talk through the science behind Alloplex's platform, how it's aiming to activate—not suppress—the body's own healing potential, and why that shift in mindset could change everything from how we treat cancer to how we think about drug development.Frank's not just a scientist or a strategist—he's someone with a lived stake in the problem. His personal experience with loss gives him a proximity-driven insight that makes this work feel urgent, not theoretical.If you're interested in biotech, systems thinking, or just want to hear from someone who's building differently—this one's worth your time.

BUFFALO, NY - May 23, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 19, 2025, titled “Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma." The study, led by first authors Leonardo Gomes da Fonseca from Hospital das Clínicas, Universidade de São Paulo, Brazil, and Federico Piñero from Hospital Universitario Austral, Argentina, investigated how patients with advanced liver cancer in Latin America respond to a widely used immunotherapy combination. The researchers found that although a minority of patients developed immune-related side effects, these events did not significantly impact overall survival. Their findings highlight the importance of early recognition and careful management of such side effects in real-world clinical settings. Liver cancer is a leading cause of cancer deaths worldwide, with limited treatment options for patients diagnosed at an advanced stage. Immunotherapy, particularly the combination of atezolizumab and bevacizumab, has become a standard approach. However, these treatments can sometimes trigger the body's immune system to attack healthy organs, leading to what are called immune-related adverse events, or irAEs. Until now, little data existed on how frequently these events occur in Latin American patients and whether they impact treatment outcomes. The researchers followed 99 patients from Argentina, Brazil, Chile, and Colombia, most of whom had cirrhosis or underlying liver disease. They received atezolizumab and bevacizumab for a median duration of six months. The researchers reported that only 18% of the patients experienced immune-related side effects, most commonly affecting the liver (hepatitis) and thyroid (thyroiditis). Most of these cases were mild or moderate, and half of them resolved completely within a month. Only eight patients needed treatment with steroids to control the immune response. Importantly, the occurrence of immune-related side effects did not affect how long patients survived after starting treatment. The median survival was the same—18.5 months—for both those who experienced irAEs and those who did not. This result suggests that while irAEs require careful management, they may not reduce the overall benefits of immunotherapy. Another significant finding was that patients with higher levels of alpha-fetoprotein (AFP), a protein often elevated in liver cancer, were more likely to experience these side effects. This information could help clinicians identify patients who need closer control during treatment. “Notably, baseline alpha-fetoprotein (AFP) values ≥400 ng/ml were significantly associated with the development of irAEs.” The study also points to key differences between clinical trial results and real-world experiences. While clinical trials report higher rates of side effects, this real-world data showed a lower incidence, possibly due to less intensive monitoring or differences in how side effects are documented in everyday practice. In summary, this study highlights that patients require ongoing vigilance and individualized care when treating liver cancer with immunotherapy. It provides valuable information to healthcare providers in Latin America and other regions with similar patient populations, aiming to improve outcomes while minimizing risks. DOI - https://doi.org/10.18632/oncotarget.28721 Correspondence to - Federico Piñero - fpinerof@cas.austral.edu.ar To learn more about Oncotarget, please visit https://www.oncotarget.com. MEDIA@IMPACTJOURNALS.COM

- Green Tea and Cognitive Benefits (0:10) - Critique of Pharmaceuticals and Big Pharma (2:39) - Green Tea and Brain Health (4:31) - Speed Cubing and Cognitive Training (10:47) - Green Tea and Cancer Prevention (15:59) - Green Tea and Heavy Metal Detoxification (24:45) - L-Theanine and Anxiety Relief (30:04) - Catechins and Polyphenols in Green Tea (36:21) - Green Tea Extracts and Supplements (39:14) - Green Tea and Cancer Therapy (50:57) - Colloidal Silver and Its Benefits (1:11:38) - Silver Nanoparticles and Cancer Research (1:23:02) - Historical and Metaphysical Significance of Metals (1:26:08) - Economic and Political Implications of Metals (1:27:53) - Challenges and Opportunities in Health and Science (1:30:08) - Personal Reflections and Future Plans (1:37:17) - Final Thoughts and Gratitude (1:41:15) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

A new study from the Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, published in Oncotarget, reveals that the gene p53, long known as the “guardian of the genome,” may be even more powerful than previously thought. By studying it in non-cancerous human cells, researchers discovered how p53 stops risky cell growth and uncovered two new potential targets for cancer therapy. Understanding p53: The Genome's Guardian Against Cancer The p53 gene is one of the most important natural defenses our body has against cancer. When functioning properly, p53 detects damage in a cell's DNA and either stops the cell from dividing or pushes it to self-destruct. This process helps prevent potentially dangerous mutations from spreading. However, many cancers find ways to silence or mutate p53, allowing uncontrolled growth and resistance to treatments. Studying p53 in a clear and accurate way has long been a challenge. Most cancer cell models used in research already carry numerous genetic mutations, which can mask or alter how p53 truly functions. To fully understand this vital tumor-suppressing gene, scientists needed a model that closely resembled healthy, genetically stable human cells—yet could still be maintained and studied over time in the laboratory. The Study: Exploring p53 in Normal and Cancer Cell Models Researchers Jessica J. Miciak, Lucy Petrova, Rhythm Sajwan, Aditya Pandya, Mikayla Deckard, Andrew J. Munoz, and Fred Bunz explored p53 activity using a uniquely suitable cell line: hTERT-RPE1. These non-cancerous human cells are immortalized using telomerase, meaning they continue dividing like cancer cells, but without the chaotic mutations seen in tumors. This makes them an excellent model for studying how p53 operates in near-normal conditions. Full blog - https://www.oncotarget.org/2025/04/22/new-insights-into-p53-a-powerful-genes-role-in-cancer-therapy/ Paper DOI - https://doi.org/10.18632/oncotarget.28690 Correspondence to - Fred Bunz - fredbunz@jhmi.edu Video short - https://www.youtube.com/watch?v=Psxj3ctbTuk Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28690 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, p53, ionizing radiation, immortalized cells, ALDH3A1, NECTIN4 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this episode, host Jonathan Sackier speaks with Alexander Spira about cutting-edge advances in lung and colorectal cancer, including EGFR and KRAS-targeted therapies. They also discuss Spira's leadership in oncology research, his thoughts on the evolving ‘town-gown' dynamic in US medicine, and his hopes for the future of cancer care.  Timestamps:  00:00 – Introduction 01:50 – Most memorable family travel adventure 03:30 – What inspired you to go into oncology 05:49 – Three recent publications in lung cancer 07:02 – Real-world data on colorectal cancer 08:15 – Sex/gender differences in non-small cell lung cancer 11:53 – The science of KRAS mutations and drug development 15:07 – Accelerating diagnostics and access to therapies 17:13 – The ‘town-gown' debate in American healthcare 18:09- Three Wishes 

Commentary by Dr. Sophie Jacob.

Episode Summary: Why is cancer on the rise—especially among younger generations?  In this powerful episode of The Art of Living Well Podcast, we sit down with Dr. Tony Jimenez to discuss the root causes of cancer, the role of integrative oncology, and his seven key principles for cancer therapy. Dr. Tony shares his personal journey into holistic cancer care, highlighting the importance of nutrition, detoxification, immune support, and emotional healing.  He also breaks down non-toxic treatments, the significance of dental health, and why practices like coffee enemas and oxygenation can make a profound impact on overall wellness. If you're looking to take proactive steps toward cancer prevention, boost your health, and gain insights into holistic healing, this episode is a must-listen!   Key Takeaways: ✅ Toxicity & lifestyle choices play a major role in cancer development  ✅ A personalized approach to nutrition is key to healing & longevity  ✅ Detoxification & immune system support are crucial for disease prevention  ✅ Coffee enemas can enhance cognitive function & boost glutathione levels  ✅ Oxygenation is essential for overall health—and it's free!  ✅ Your oral microbiome & dental health directly impact your body's wellness  ✅ Emotional healing & trauma work are vital for long-term health Tune in now to learn how you can take charge of your health and longevity! Chapters 08:26 Understanding Cancer: Causes and Growth 19:47 Trends in Cancer: What We're Seeing Today 20:16 The Seven Key Principles of Cancer Therapy 34:05 The Power of Coffee Enemas 38:38 Understanding the Microbiome 41:27 Dental Health and Toxicity 53:00 The Emotional Component of Healing 01:00:10 Practical Steps for Longevity We'd love to hear your thoughts! Connect with us on social media or email us at theartoflivingwellpodcast@gmail.com

Dr. Antonio Jimenez discusses the innovative treatments and holistic approach at Hope4Cancer Treatment Centers. Learn about the comprehensive strategies used to combat cancer and support healing. #CancerTreatment #HolisticHealth #Hope4Cancer

Big Pharma, Big Tech, and the Deep State don't want you to hear this conversation, but Dr. Pierre Kory and I expose their lies anyway. The war on medicine is real—COVID was just the beginning. Now they're rolling out mRNA tech for cancer, embedding AI in biotech, and pushing a transhumanist agenda that turns humans into lab rats. What's worse? They're gaslighting us, poisoning our food, manipulating our health, and calling it “science.” We break down why RFK Jr. is the man to finally dismantle this corrupt system, the lies behind the cancer industry, and why so many people are sick, infertile, and dying young. This is the medical-industrial complex's worst nightmare.Dr Pierre Kory and Jeff Dornik will both be speaking at the upcoming Summit for Truth & Wellness in Rochester, NY, on March 29th, alongside Mary Holland, Naomi Wolf, Dr Mary Talley Bowden and Shannon Joy. Get your tickets at https://summitfortruth.com.Follow Dr Pierre Kory on X: https://x.com/PierreKoryFollow Jeff Dornik on Pickax: https://pickax.com/jeffdornikFollow Maverick Broadcasting on Pickax: https://pickax.com/maverickbroadcastingPrepare for the next pandemic with the Contagion Emergency Kit from The Wellness Company, offering life-saving medications like Ivermectin, Hydroxychloroquine, Azithromycin, Oseltamivir, and Budesonide. Use code JEFF for 10% off and ensure you have the necessary tools and guidance at the ready. https://twc.health/jeff

Dermatologic toxicities associated with oncology treatment can significantly impact quality of life and treatment adherence for patients with breast cancer. The Association of Cancer Care Centers (ACCC) is committed to providing up-to-date guidance on managing these dermatologic side effects to enhance clinical outcomes. In this episode of CANCER BUZZ, Allison Gordon, MD, a supportive oncodermatologist at Memorial Sloan Kettering Cancer Center, discusses the dermatologic toxicities associated with breast cancer treatment. Dr Gordon explores preventive measures that oncologists can implement early in the treatment course and offers alternative resources for oncology clinicians when an oncodermatologist referral is not feasible. Additionally, she highlights capivasertib, a recently approved antineoplastic drug, and reviews its associated cutaneous adverse events, along with supportive care and management strategies. Thank you to AstraZeneca for their support of this program.   Allison Gordon, MD Dermatologist Memorial Sloan Kettering Cancer Center New York, NY   “Because many of these medications can cause dry skin, which can be debilitating for patients... [we recommend] using a thick ointment or cream moisturizer on their damp skin after they shower... it doesn't have to be anything expensive... I always recommend that to all patients regardless of what treatment they're on.”– Allison Gordon, MD    Additional Reading/Sources  ACCC Supportive Care Strategies for Dermatologic Toxicities Related to Cancer Therapies education program (https://www.accc-cancer.org/home/learn/comprehensive-cancer-care-services/dermatologic-toxicities?)   Targeted Therapy Side Effects – American Cancer Society  (https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy/side-effects.html)   Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569770/)   Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy (https://ascopubs.org/doi/10.1200/EDBK_289911)   Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatolgy Study Group (https://mascc.org/resources/mascc-guidelines/)   Guidelines for the Prevention and Treatment of Radiation-Induced Skin Reactions (https://mascc.org/resources/mascc-guidelines/)   Guidelines for Prevention and Management of Dermatological Toxicities Related to Anticancer Agents (https://pubmed.ncbi.nlm.nih.gov/33248228/)

Cancer rates are at an all-time high...     And while conventional treatments continue to advance, there are natural therapies being widely used in other parts of the world that remain underutilized in the United States.     One such therapy is mistletoe extract, a plant-based treatment that has been shown to support immune function and improve quality of life in cancer patients.      So on today's Cabral Concept 3315, I want to dive into the latest research on mistletoe therapy, its potential benefits, and what the science really says about its role in integrative cancer care. Enjoy the show, and let me know your thoughts!   - - - For Everything Mentioned In Today's Show: StephenCabral.com/3315 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Neuropathy, or painful nerves, are seen in more than 40% of people who've been treated for cancer, a recent study reports. Kimmel Cancer Center director William Nelson at Johns Hopkins says the magnitude of the problem is huge, although there … Can painful nerve pain following cancer therapy be avoided? Elizabeth Tracey reports Read More »

Got Health Questions or Comments?

Cancer diagnosis and treatment are the primary focus of Dr. Narjis Fatima's research in Australia. She provides insight into the range of services available for cancer prevention and treatment, emphasizing the accessibility of affordable, and targeted therapy options. - ڈاکٹر نرجس فاطمہ آسٹریلیا میں کینسر کے مرض کی تشخیص اورعلاج پر تحقیق کر تی ہیں۔ وہ بتاتی ہیں کہ آسٹریلیا میں کینسر سے بچاؤ اور اس کے علاج کے لئے کس طرح کی مفت، کم قیمت اورٹارگیٹیڈ تھراپی خدمات فراہم کی جاتی ہیں۔

Part 1 of 2: Our guest today is Kate Yen, Founder and CEO of Auron Therapeutics. Auron Therapeutics leverages cutting-edge science and AI-powered analysis to develop next-generation cancer therapies by mapping key drivers of tumorigenesis. Kate earned her Ph.D. in Biological Chemistry from UCLA, where she also completed her postdoc. She held roles at Merck and as a UCLA professor before joining Agios Pharmaceuticals, where she led the IDH translational research team behind two FDA-approved IDH mutant inhibitors and co-led the discovery of vorasidenib, a promising glioma therapy now in clinical development. With deep expertise in preclinical and clinical research, a proven track record in advancing breakthrough therapies, and a passion for oncology, Kate's journey and insights are invaluable.

GSD Presents:Balancing Lives and Profits in Cancer Therapy Development with Peter TraversJanuary 31st, Friday#GSDPresents #CancerTherapy #HealthcareEthics #MedicalInnovation #LifeVsProfit #PharmaDebate #Biotech #HealthcareTech #EthicalAI #FutureOfMedicine #CancerResearch #AIinHealthcare #PatientFirst #MedicalBreakthroughs #HealthcareEquity

John Richardson, Founder & Chief Visionary Officer of Operation World Without Cancer and Founder of Richardson Nutritional Center, passionately shares his family's advocacy for Laetrile, a natural cancer treatment derived from apricot seeds, and recounts powerful success stories in its application. The episode provokes critical questions about the mainstream medical approach to cancer and encourages listeners to explore natural remedies as essential health strategies. • The origins of John's family's journey in cancer treatment • Fundamental chemistry of amygdalin within apricot seeds • Case study of little Shane Horton's dramatic recovery • The importance of nutrition in prevention and combatting cancer • Challenges faced by alternative treatments in a pharmaceutical-dominant environment • Launching Operation World Without Cancer to consolidate natural treatment strategies • Call to action: Explore a holistic approach to health and wellnessLearn more about John and his mission.Shop apricot seeds or Laetrile products and save with this HealingStrong discount. Automatically applied. HealingStrong's mission is to educate, equip and empower our group leaders and group participants through their journey with cancer or other chronic illnesses, and know there is HOPE. We bring this hope through educational materials, webinars, guest speakers, conferences, community small group support and more.Please consider supporting our mission by becoming a part of our Membership Program, as a monthly donor.When you do, you will receive additional resources such as: webinars, access to ALL our past and most recent conference videos, downloadables and more, as a bonus.To learn more, head to the HealingStrong Membership Program link below: Membership Program

Anne Blaes, MD, and Nicholas Wilcox, MD, MHS discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular care and surveillance after cancer therapy, including available evidence, practical recommendations, and key evidence gaps.

In the previous episode we heard how some rationally-designed therapies work on almost any cancer with the right molecular signature. Tumour-agnostic medications could be godsend for patients with rare cancers which have classically been overlooked by drug developers, and those with advanced cancers of unknown origin. 15,000 such patients have undergone comprehensive genome profiling of their tumours through the organisation, Omico. In this podcast, Omico's founder explains that while the majority have received recommendations about matched therapies, clinical trials are typically the only way to enable access. Professor David Thomas discusses why Australia's Health Technology Assessment process appears to be so conservative and how the market price of next-generation oncotherapies might be brought down by changes across the local ecosystem. Guest Prof David Thomas FRACP PhD (Director, Centre for Molecular Oncology UNSW; Founder and Chief of Science, Omico)  Professor Thomas or Omico have received grants, consultancies or research support from Roche, Astra Zeneca, Pfizer, Eisai, Illumina, Beigene , Elevation Oncology, RedX Pharmaceuticals, SunPharma , Bayer, George Clinical, Novotech , Merck Sharpe and Dohme, Boehringer Ingelheim, Hummingbird, Microba , BioTessellate , PMV Pharma, Australian Unity and Foundation Medicine. ProductionProduced by Mic Cavazzini DPhil. Music licenced from Epidemic Sound includes  ‘Multicolor' and ‘Pulse Voyage' by Chill Cole. ‘Impulsing', ‘the City of Hope' ‘Over Again', and ‘Going Undercover' by Borrtex provided courtesy of FreeMusicArchive. Image by Guido Mieth licenced through Getty Images.  Editorial feedback kindly provided by RACP physicians Simeon Wong, Stephen Bacchi. Thanks also to Kym Bramich and Arnika Martus on staff with Omico and RACP respectively.  Please visit the Pomegranate Health web page for a transcript and supporting references.Login to MyCPD to record listening and reading as a prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health' in Apple Podcasts, Spotify,Castbox or any podcasting app.

Myeloperoxidase (MPO) is a vital enzyme in the immune system, with the potential to revolutionise antiseptics and cancer therapy.Professor Robert C. Allen has developed MPO-based antiseptics effective in blood which are systemically safe, while also demonstrating selective anticancer properties. Together with Jackson T. Stephens, the work overcomes obstacles to bring these therapies into widespread use, offering promising solutions for infection control and bladder cancer treatment.Read more in Research FeaturesRead the original research: doi.org/10.1158/1538-7445.AM2024-2029

Immunotherapies for cancer can be lifesavers, but they can also provoke an overwhelming immune response that can be life threatening. Now a Johns Hopkins study may help pinpoint who is at risk for this type of reaction. Kimmel Cancer Center … It may now be possible to tell who is going to react badly to some forms of cancer therapy, Elizabeth Tracey reports Read More »

Sivatharshini Ramalingam, MD, and Charlotte Manisty, MBBS, PhD, discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular risk evaluation prior to cancer treatment, cardiac nuances of therapy and highlight evidence gaps for future direction of research.

Commentary by Dr. Beshay Zordoky.

On this episode of the Crazy Wisdom Podcast, host Stewart Alsop welcomes Swati Chaturvedi, CEO of Propel X, to explore the world of deep tech, frontier technology, and the forces shaping the future of human progress. Swati shares her decade-long journey in deep tech, reflecting on how the term evolved as a response to the "tech startup" boom, and discusses her focus on companies leveraging breakthroughs in science and engineering for humanity's advancement. The conversation touches on the role of government support, the power of hypothesis-free experimentation, and the critical importance of partnerships between startups and large corporations. They also discuss transformative technologies like AI, autonomous drones, bioinformatics, robotics, and the possibilities and perils of human augmentation. For more insights from Swati, visit Propel X at www.propelx.com or connect with her on LinkedIn, where she shares her thoughts on innovation, R&D, and the future of technology.Check out this GPT we trained on the conversation!Timestamps00:00 Introduction to the Crazy Wisdom Podcast00:16 Defining Deep Tech and Its Evolution03:06 Challenges and Philosophical Insights in Deep Tech07:07 AI's Role in Engineering and Bioinformatics14:22 Future Shock and Human Augmentation14:35 The Evolution of Science and Technology22:58 The Future of Work and Social Dynamics24:06 Exploring Sci-Fi Genres: Cyberpunk vs. Solarpunk25:25 Exploring Solar Punk and Human Problems26:01 The Promise and Limitations of Deep Tech26:39 Economic Realities of Technological Advancements27:16 Future Impact of Emerging Technologies28:58 Challenges in Ag Tech and Environmental Concerns29:30 Global Environmental Change and Human Activity33:53 The Role of Modeling in Predicting Climate Impacts36:22 Scientific Method and Industry Collaboration39:23 Government's Role in Early Stage Research42:34 Investment Strategies in Deep Tech46:27 Consumer and Corporate Markets for New Technologies49:12 Conclusion and Future DiscussionsKey InsightsThe Rise of Deep Tech as a Distinct Category: Swati Chaturvedi explains how the concept of "deep tech" emerged as a response to the overuse of the term "tech startup" during the heyday of consumer technology. Unlike simple software apps like photo-sharing or delivery platforms, deep tech focuses on companies leveraging scientific and engineering breakthroughs to solve fundamental human challenges. This includes innovations in fields like AI, robotics, life sciences, space technology, and advanced materials. Her 2014 blog post defining deep tech has since become a widely referenced resource in the field, signaling a shift in focus from digital consumer solutions to tangible, science-based advancements.The Role of Hypothesis-Free Experimentation: Traditional scientific research follows a hypothesis-driven approach, where scientists predict outcomes before testing. Swati highlights the transformative potential of "hypothesis-free" experimentation, where AI and machine learning allow for large-scale experimentation without predefined assumptions. This approach mirrors the randomness of evolution, enabling faster discovery of unexpected results. Companies like Helix are applying this method in drug discovery, where AI-driven processes identify new therapeutic compounds. This shift could significantly accelerate R&D timelines and reduce costs in fields like pharmaceuticals and materials science.The Power of Government Support in Early-Stage R&D: Swati emphasizes the essential role of government funding in de-risking early-stage research. Through programs like SBIR (Small Business Innovation Research) grants, government agencies like the NSF (National Science Foundation) and the Department of Defense (DoD) fund exploratory research at universities and small businesses. These grants act as the "seed fund of America," investing billions annually into high-risk, high-reward projects. Companies that receive these grants often have their private sector investments matched by government dollars, providing significant leverage for investors and entrepreneurs. This public-private funding model enables startups to bridge the "valley of death" between research and commercialization.The Critical Role of Corporate-Startup Partnerships: Swati highlights the importance of partnerships between startups and established corporations, especially in deep tech. These joint development projects allow startups to access resources, validate their markets, and co-develop products with corporate customers. While some founders worry about protecting their intellectual property (IP), Swati believes that the benefits of corporate partnerships outweigh the risks. Corporate collaborations offer crucial early traction and revenue, helping startups de-risk their path to market. This is especially vital in sectors like healthcare, robotics, and clean energy, where the cost of developing and commercializing products is exceptionally high.AI as a Force for Human Augmentation: The episode explores AI's role as an augmentative force rather than a replacement for human intelligence. Swati notes that AI is best understood as a tool that allows humans to multiply their cognitive abilities—processing vast amounts of information, identifying patterns, and making faster connections. This augmentation goes beyond software, extending into physical augmentation with devices like robots and smart tools that help humans accomplish physical tasks. While AI-driven tools like ChatGPT may lead to job displacement, Swati sees it as a natural progression, requiring humans to upskill and shift to higher-value tasks.The Promise and Risks of Climate and Environmental Technologies: Swati identifies climate change and global environmental degradation as existential challenges that even the most advanced deep tech may struggle to address. Technologies like atmospheric water generation, carbon capture, and agtech are making strides, but she notes that they are not yet sufficient to solve global challenges like water scarcity, food security, and air pollution. Drawing from her personal experience with air pollution in India, Swati argues that we need to better price and internalize the "cost of the commons"—the shared environmental resources that are often depleted for private gain. Without a clear economic incentive to prevent environmental harm, she warns that climate issues will continue to escalate.The Future of Space Tech and Human Exploration: Swati expresses optimism about the commercialization of space technology, noting its growing impact on daily life. Technologies like satellite internet (e.g., Starlink) are already improving connectivity in remote areas worldwide. The use of satellites for earth observation, weather tracking, and resource management is also becoming essential for sectors like agriculture and disaster response. Looking ahead, Swati is bullish on the potential for space colonization on the moon and Mars, although she acknowledges the immense technical and ethical challenges involved. While space tech once felt like science fiction, companies like SpaceX have made it tangible and real.

When it comes to supporting the body's natural detox and healing processes, the lymphatic system is often an unsung hero. As Founder and CEO of Medella Health, Desiree De Spong created Flowpresso, a 3-in-1 therapy combining compression, heat, and deep pressure to enhance lymphatic flow and detoxification. In our conversation, Desiree shares practical strategies for optimizing lymphatic health and how regular lymphatic drainage can lead to profound health benefits. She highlights the importance of supporting the detoxification and elimination pathways, and signs your body needs cleansing and purifying. Finally, Desiree details the creation and benefits of the innovative Flowpresso technology and its at-home tools so you can regularly give your lymphatic system the attention and care it deserves.DISCLAIMER: This podcast is for educational purposes only and not intended for diagnosing or treating illnesses. The hosts disclaim responsibility for any adverse effects from using the information presented. Consult your healthcare provider before using referenced products. This podcast may include paid endorsements.THIS SHOW IS BROUGHT TO YOU BY:SOLTEC | Visit lukestorey.com/soltec and use code LUKE2024 to get the best available discount on your Soltec Health System.MAGNESIUM BREAKTHROUGH | Use code LUKE10 for 10% off at bioptimizers.com/luke.LEELA QUANTUM TECH. | Go to lukestorey.com/leelaq and use the code LUKE10 for 10% off their product line.BON CHARGE | Use the code LIFESTYLIST for 15% off at boncharge.com/lifestylistMORE ABOUT THIS EPISODE:(00:00:00) Introduction(00:00:08) Healing Trauma Through Activating the Lymphatic System(00:09:23) Lymphatic Basics(00:19:25) Cancer Therapies & Safe Practices for Vibration Plates & Dry Brushing(00:36:48) The Four Pathways of Elimination(00:58:17) Changing Stress, Anxiety, & Sleep with Flowpresso(01:21:57) Finding a Practitioner & Optimizing Your Treatment (01:29:26) Flow at Home Portable ToolsResources:• Website: flowpressousa.com (Use code LUKE for $10 off Flow Orb and Flow Vibrate and $555 off Flowpresso)• Instagram: @flowpresso_intThe Life Stylist is produced by Crate Media.

Join Dr. Martin in today's episode of The Doctor Is In Podcast.  

Although initial clinical trials of tamoxifen as a treatment of breast cancer were positive, Imperial Chemical Industries (ICI) did not believe this market would be commercially viable. The company had hoped for a contraceptive pill – tamoxifen didn't work for that – not a cancer treatment. In 1972 the higher-ups at ICI decided to cancel the research. But Dora Richardson, the chemist who had originally synthesized the compound, and her boss, Arthur Walpole, were convinced they were on to something important, something that could save lives. They continued the research in secret. Tamoxifen was eventually launched in the U.K. in 1973 and went on to become a global success, saving hundreds of thousands of lives. Dora Richardson's role in its development, however, was overshadowed by her a male colleague and all but forgotten.

Episode #243 Jonathan Otto, Secret Cancer Therapies (PART 1) Hello Health Heroes!  This week I interviewed Jonathan Otto who worked on the Truth about Cancer project for many years. Since then Jonathan has been making documentaries and doing investigative journalism into natural health solutions. He shares the knowledge he gained over the years from the doctors and healers he learned from and today we focus on cancer which is growing at an alarming rate. We hope that you find some gold nuggets in this interview for yourself or someone you know that is going through cancer and is looking for more options. I have to add that living a daily detox lifestyle is the best way to protect and prevent one from ever getting cancer in the first place. Enjoy the show! Love & Light Coach Tim  p.s. Please like & subscribe to my show for more great inspiration and education so that you can become your own doctor and learn to self heal! p.p.s. To contact Jonathan go to: https://myredlight.com use the discount code “healthhero” to save 10% on your purchase! Tim's Favorite, HIGHEST QUALITY Health Product Recommendations: Best Detox & Nutrition Supplements: https://www.chemicalfreebody.com/  Best Hydrogen Machine: Tim's personal unit - CLICK HERE Best Infrared Saunas & Healing Lamps: Tim's personal unit - Save $100 CLICK HERE Water Purification/Restructuring System: Book FREE Consult CLICK HERE Best Home Air Purification Unit : Tim's personal unit CLICK HERE Best Non Toxic Home Building Materials: CLICK HERE  See omnystudio.com/listener for privacy information.

Cancer research has made remarkable progress in recent years, with monoclonal antibody (mAb) therapy emerging as one of the most promising advancements. These treatments are designed to precisely target cancer cells, offering a more focused approach that helps patients fight different malignancies with fewer side effects compared to traditional chemotherapy. Despite this progress, a major challenge remains: targeting cancer-related molecules inside cells rather than on the surface, which has been the main focus of available mAb therapies until now. This is where the groundbreaking research in the paper “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition,” published in Volume 15 of Oncotarget on October 1, 2024, comes into play. Full blog - https://www.oncotarget.org/2024/10/24/next-generation-antibodies-for-cancer-therapy/ Paper DOI - https://doi.org/10.18632/oncotarget.28651 Correspondence to - Peter M. Glazer - peter.glazer@yale.edu Video short - https://www.youtube.com/watch?v=sTHjJ0Qq0YQ Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28651 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, 3E10, cell penetration, nucleic acid binding, nucleic acid delivery, RAD51 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Here are the show notes for The James Altucher Show episode featuring Naveen Jain:A Note from James:“Oh my gosh. What a podcast with Naveen Jain. I first had Naveen on in 2014 or 2015, and he remembered it perfectly. That conversation was so fun, I still remember it like it was yesterday. It's crazy because I've done over 1,500 episodes, but that one stuck with me.Back then, we talked about Moon Express and his journey building rockets to the moon. Now, almost ten years later, Naveen has built several other companies, including Viome, which uses cutting-edge technology to analyze your microbiome and help people live longer healthier lives. Today, we're talking about his new book, The Youth Formula: Outsmart Your Genes and Unlock the Secrets to Longevity.At first, I'll admit, I was tired of hearing about longevity—everyone seems to be saying the same thing—but Naveen has such a unique take on it. We got into everything: from the role of microbes in our health to fecal transplants (yes, really) and how bacteria can influence personality traits. It was fascinating. We even talked about how changing your microbiome could literally alter your personality.There's so much in this episode that it's going to blow your mind. I hope it's not another ten years before we get Naveen back on the show. I'm definitely going to take him up on some of his suggestions, and maybe I'll have some results to share in a few months. Here's Naveen Jain.”Episode Description:In this episode, James Altucher is joined by serial entrepreneur Naveen Jain to explore the cutting-edge science of longevity, gut health, and human potential. Naveen, the founder of Viome and author of The Youth Formula, dives deep into how the microbiome shapes our health and even our personality. He explains why genes aren't destiny, how microbes may play a more important role in our health than DNA, and what steps we can take to live longer healthier lives. James and Naveen also discuss the surprising science behind fecal transplants, the future of personalized nutrition, and why finding purpose might be the ultimate key to longevity.What You'll Learn:How the microbiome plays a crucial role in your overall health—and might even affect your personality.Why DNA isn't as important as you think when it comes to disease and longevity.The latest research on fecal transplants and their impact on treating various diseases.How personalized nutrition can help you optimize your health based on your unique biology.The connection between purpose, community, and living a longer life.Timestamped Chapters:[01:30] Introduction: Reconnecting with Naveen Jain after 10 years[02:44] The Youth Formula and Viome: Outsmarting your genes[03:17] Microbiome's role in health: 99.999% of your body is microbes[04:02] Fecal transplants and personality: Can you inherit personality traits?[06:00] Personalized nutrition: Why “healthy” food isn't healthy for everyone[12:00] The power of purpose: Why having a reason to live is crucial for longevity[21:32] Changing the microbiome to treat disease: Fecal transplants and immunotherapy[29:24] How microbiomes affect mental health: Serotonin and gut-brain connections[39:51] The role of AI in personalized health recommendations at Viome[46:00] Stress and the sympathetic/parasympathetic modes: Modern stressors vs. ancient survival instincts[48:01] The role of exercise: Why 30-45 minutes of movement is enough[49:00] Sleep and health: The importance of quality over quantity[56:58] Entrepreneurial insights: Why a smooth life isn't what you want as an entrepreneur[58:07] Long-term vision: How Viome is focused on extending life by improving microbiome health[65:00] Wrap-up: James's thoughts on the future of health and Naveen's closing remarksAdditional Resources:The Youth Formula: Outsmart Your Genes and Unlock the Secret to LongevityViome: Learn more about personalized nutrition and microbiome analysis.Naveen Jain's Official Website ------------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn what I learned at jamesaltuchershow.com------------Thank you so much for listening! If you like this episode, please rate, review, and subscribe to “The James Altucher Show” wherever you get your podcasts: Apple PodcastsiHeart RadioSpotifyFollow me on social media:YouTubeTwitterFacebookLinkedIn

—- 

Synopsis: Explore the forefront of biotech innovation as host Rahul Chaturvedi interviews Dr. Dave Bearss, Co-Founder & CEO of Halia Therapeutics, in this engaging episode of Biotech 2050. Dr. Bearss shares the story behind Halia's pioneering genetic discoveries and their mission to tackle Alzheimer's disease. Learn about the science driving breakthrough therapies that target neuroinflammation, offering hope in the fight against neurodegenerative disorders. Packed with insights and inspiration, this episode is a must-listen for anyone interested in the future of healthcare and biotech innovation. Biography: Dr. David J. Bearss, a serial entrepreneur and pharmaceutical innovator, has over two decades of experience spanning academic and industrial roles. His expertise lies at the intersection of structure-based small-molecule drug discovery and the utilization of genetic model systems for drug discovery. Dr. Bearss's career is marked by significant achievements, with a strong foundation in translational research focused on drug advancement to the clinic and using genetic markers for predictive drug sensitivity. Notably, Dr. Bearss has discovered 16 compounds that have successfully navigated from discovery in the lab to IND into clinical development. His entrepreneurial experience is evident through his roles as the co-founder of eight biotechnology companies. More importantly, his unwavering commitment to advancing novel drug development truly sets him apart. Before taking on his role as chief scientific officer at Halia in January 2021 and assuming the CEO position in March 2022, Dr. Bearss served as the CEO of Tolero Pharmaceuticals, an organization later acquired by Sumitomo Dainippon Pharma in 2017. His tenure as chief scientific officer at Montigen Pharmaceuticals, followed by its acquisition by SuperGen Inc., demonstrates his dedication to driving early-stage drug discovery and development. At SuperGen, he continued to develop his expertise in these critical areas. Dr. Bearss's academic career is equally impressive. It led to his founding role as the Center for Investigational Therapeutics Co-Director at the Huntsman Cancer Institute. He also held academic positions as an Associate Professor in the Department of Oncological Sciences at the University of Utah and as an Associate Professor of Physiology and Developmental Biology at Brigham Young University, demonstrating his deep knowledge and expertise in these fields. Dr. Bearss's academic career began with a Ph.D. in cell biology from the University of Texas Health Science Center in San Antonio, Texas, and a post-doctoral fellowship at the Institute for Drug Development at the Cancer Therapy and Research Center also in Texas. He has won several awards for his entrepreneurial and scientific achievements, including the Utah Governor's Medal of Science and BIO Utah Entrepreneur of the Year.

The latest on breast cancer research therapies and the questions to be asking your doctor. Also, the story behind a wine company that solved the issue of enjoying one glass without wasting the bottle. Plus, Eugenio Derbez joins to discuss his new series, ‘Y Llegaron de Noche.' And, actress and model Elizabeth Hurley shares details about Estée Lauder Companies' Breast Cancer Campaign.

In this episode on systemic, non-CNS cancer therapies and brain health, with Drs. Michael Parsons and Jorg Dietrich, we discuss basic concepts in cancer biology, the impact of cancer therapies on cognition, mechanisms by which non-CNS treatments impact brain health, the role of the immune system in treatment, immune system overactivation and cognitive side effects, the burgeoning field of cancer neuroscience, and the role of neuropsychologists in assessment, management, and treatment of patients with systemic cancers. Show notes are available at www.NavNeuro.com/152 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS  2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating   Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

Have you ever wondered if the key to your overall well-being lies in your gut? In this episode, Gary Brecka explores the fascinating world of the gut microbiome and its profound impact on your health. Discover how the trillions of microbes living in your gut not only aid in digestion, but also play a crucial role in your mental health, immune system, and overall vitality. They also shared the science behind microbiome, how diet and lifestyle choices can transform your gut health, and why conventional medicine alone isn't always enough. As Dr. Will B stated, “The food choices that you make today will start to impact your microbiome by tomorrow.” How will you begin nurturing your gut today? Let us know in the comments below! Connect with Dr. Will B: Instagram: https://www.instagram.com/theguthealthmd?igsh=MWkyejllcWo5aWo3Mw== Website: https://theplantfedgut.com/  “Fiber Fueled” (Dr. Will B's Book): https://theplantfedgut.com/book/  38TERA (Your Gut's New Bestfriend): https://38tera.com/ TIMESTAMPS:  00:00 ​Intro of Show and Guest 02:31 ​Dr. Will B's Transformative Journey  07:23 ​The New Science of Microbiome 11:31 ​Gut Microbiome's Impact on Our Health 14:51 ​Feeding Your Microbiome 15:14 ​Inside the Intestine: Microbes' Existence as an Ecosystem 17:10 ​Gut Microbiome's Disturbance Potentially Causing Mental Disorders  19:08 ​Healthy Microbiome Diet and Lifestyle 22:21 ​Power of Fermented Foods 25:42 ​Cancer Therapies and Microbiome 31:36 ​Feeding Microbes with Fiber 33:14 ​Risks of Colon Cancer  39:26 ​Plant Sources of Fiber 44:55 ​Gut Microbiome Tests and Checking Yourself 59:20 ​Basic and Healthy Gut Nutrition 01:01:47 ​Probiotic Studies 01:05:03 ​Preventative Measures  01:06:43 ​Connect with Dr. Will 01:11:46 ​Final Question: What does it mean to you to be an “Ultimate Human?” Get weekly tips from Gary Brecka on how to optimize your health and lifestyle routines: https://bit.ly/4eLDbdU Order The 1 Genetic Test That Will Give You Results For Life Here: https://bit.ly/3L5k8hl Get The Supplements That Gary Recommends Here: https://bit.ly/4cMDGm7 Sign up for 10X Health Affiliate Program: https://bit.ly/3ROGPd6 PLUNGE - Use code “Ultimate” for $150 off your order of the best cold plunge & sauna in the US: https://bit.ly/3yYE3vl EIGHT SLEEP - Use code “GARY” to get $350 off Pod 4 Ultra: https://bit.ly/3WkLd6E ECHO GO PLUS HYDROGEN WATER BOTTLE: https://bit.ly/3xG0Pb8 BODY HEALTH - Use code “ULTIMATE10” for 10% OFF YOUR ORDER: https://bit.ly/4cJdJE7 Discover top-rated products and exclusive deals. Shop now and elevate your everyday essentials with just a click!: https://theultimatehuman.com/amazon-recs Watch “The Ultimate Human Podcast with Gary Brecka” every Tuesday and Thursday at 9AM ET on YouTube: https://bit.ly/3RPQYX8 FOLLOW US: The Ultimate Human on Instagram: https://bit.ly/3VP9JuR The Ultimate Human on TikTok: https://bit.ly/3XIusTX The Ultimate Human on Facebook: https://bit.ly/3Y5pPDJ Gary Brecka on Instagram: https://bit.ly/3RPpnFs Gary Brecka on TikTok: https://bit.ly/4coJ8fo Gary Brecka on Facebook: https://bit.ly/464VA1H SUBSCRIBE TO: https://www.youtube.com/@ultimatehumanpodcast https://www.youtube.com/@garybrecka Download “The Ultimate Human with Gary Brecka” podcast on all your favorite platforms: https://bit.ly/3RQftU0 The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nurses Out Loud – In this episode, we explore alternative cancer therapies and alternatives to traditional health insurance models. We pay tribute to Dr. Jim Meehan, who recently passed away after a battle with cancer. Dr. Meehan was a fierce advocate for medical freedom, informed consent, and vaccine safety. His legacy and contributions to the movement are profound and enduring. Join us in honoring his impactful life and work.

In this episode of the Dr. Jockers Functional Nutrition Podcast, Dr. David Jockers delves into our body's innate ability to heal itself, offering practical strategies for daily wellness. His conversation with Dr. Tony Jimenez adds depth, exploring non-toxic, integrative approaches to treating cancer and enhancing immune system function.   Dr. Jimenez shares insights into the complex nature of cancer cells and the critical role of the immune system in combating disease. His expertise in integrative oncology provides a compelling look at how small changes can significantly impact overall health.   Tune in for a powerful discussion on thriving through natural healing. Whether facing health challenges or aiming for peak wellness, this episode will equip you with the knowledge and motivation to take control of your health journey. Join us to learn how to harness your body's healing potential and achieve a vibrant, healthy life. In This Episode:   00:00 Introduction to Quality of Life Parameters   03:08 Introduction to Dr. Tony Jimenez 05:03 Dr. Tony Jimenez's Journey into Integrative Oncology 08:14 Understanding Telomeres and Their Impact on Health 12:34 Fasting and Its Benefits for Cancer Therapy 20:10 Seven Key Principles of Cancer Therapy 28:27 Research and Data Collection at Hope for Cancer 30:22 Understanding Cancer Cell Metabolism 31:04 Blood Sugar Levels in Cancer Patients 33:34 Inflammation and Cancer Progression 36:18 Blood Flow and Tumor Growth 39:55 Vitamin D and Cancer 44:16 Quality of Life in Cancer Treatment 47:41 Survival Rates and Integrative Approaches 50:35 Words of Inspiration and Hope 57:22 Conclusion and Final Thoughts   This podcast is sponsored by ShopC60.com. C60 is a powerful, Nobel Prize-winning antioxidant, that helps to optimize mitochondrial function, fights inflammation, and neutralizes toxic free radicals! I'm a big fan of using C60 in conjunction with your keto and intermittent fasting lifestyle to support your immune system, help your body detox, and increase energy and mental clarity. My favorite C60 products for Keto & IF lifestyles include C60 Purple Power in Organic MCT Coconut Oil (you can add this to your coffee) and their delicious Sugar-Free C60 Gummies (made with allulose and monk fruit)! If you are over the age of 40, and you'd like to kick fatigue and brain fog to the curb this year, visit shopc60.com and use the coupon code “JOCKERS” for 15% OFF  and start taking back control over your health today!   Have you heard of Paleovalley's amazing Turmeric Complex? It contains whole food and organic turmeric instead of just isolated curcumin.    And we know that organic turmeric is way better, and one of the best things you can take to shut down inflammation in the body and support healthy blood flow and blood pressure.    It also includes coconut oil and black pepper as its ingredients, which has been shown to improve the absorption of turmeric by 2000%! Plus, there's also organic ginger, rosemary, and cloves which synergize with the turmeric to help improve digestion and blood sugar.   Paleovalley's Turmeric Complex also supports joint health, mental clarity, and improved brain function. You've just got to try this product. Visit paleovalley.com/jockers!     “We need to stimulate the body's self-healing mechanisms; our body was wonderfully created to heal itself.” -Dr. Tony Jimenez     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean  TuneIn Radio   Resources: Visit https://shopc60.com/jockers – Use code “JOCKERS” to get 15% off! Paleovalley's Turmeric Complex - visit paleovalley.com/jockers     Connect with Dr. Tony Jimenez: Website - https://hope4cancer.com/ Book - https://amzn.to/4ctIaix   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/   If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/